指南与共识慢性肾脏病

2017 KDIGO CKD-MBD 指南更新实施:亚洲峰会会议报告

2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report.
指南 / 共识 · Kidney Int Rep · 2019-09-23

KDIGO 于 2017 年对 CKD-MBD 指南进行选择性更新,并于 2018 年 4 月在日本召开实施峰会,讨论亚洲 8 个国家/地区采纳指南的障碍。峰会提出医患共同决策、基于风险获益的个体化护理及与肾脏病学会合作教育等策略。

要点

  • 2017 KDIGO CKD-MBD 指南为选择性更新,需结合当地药物可及性与报销政策实施。
  • 亚洲峰会建议医患共同决策,并根据治疗风险获益比进行个体化护理。
  • KDIGO 可与本地及国家肾脏病学会合作,提供教育并促进指南实施。

核心结论

  • 亚洲峰会提出的多层面策略框架可能有助于克服指南实施障碍,并为其他地区提供参考。

研究设计与样本

  • 2018 年 4 月 KDIGO 在日本召开 CKD-MBD 指南实施峰会,讨论 8 个亚洲国家/地区的实施障碍。

主要发现

  • 峰会讨论了 CKD-MBD 药物可及性及政府卫生政策对报销和实践模式的影响。
  • 峰会参与者提出了医患共同决策和基于风险获益比的个体化护理方法。

临床怎么用

  • 临床可采用医患共同决策,根据治疗风险获益比进行个体化 CKD-MBD 管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Improving Global Outcomes (KDIGO) Clinical Practice Guideline on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) 2009 provided recommendations on the detection, evaluation, and treatment of CKD-MBD in patients CKD who are and are not undergoing dialysis. Because of the accumulation of evidence since this initial publication, the CKD-MBD Guideline underwent a selective update in 2017. In April 2018, KDIGO convened a CKD-MBD Guideline Implementation Summit in Japan with the key objective to discuss various barriers to the uptake and implementation of the CKD-MBD Guideline in 8 Asian countries/regions. These countries/regions were comparable according to their high-to-middle economic ranking assigned by the World Bank. The discussion took into account the availability of CKD-MBD medication therapies and government health policies that may influence reimbursement and practice patterns in the region. Most importantly, Summit participants developed a framework of multifaceted strategies aimed at overcoming barriers to guideline implementation. The Summit attendees suggested a shared decision-making approach between clinicians and patients in CKD-MBD management, as well as individualized care based on the treatment risk-benefit ratio. The Summit participants also discussed how KDIGO, as a guideline development organization, may work in partnership with local and national nephrology societies to provide education and facilitate implementation of the guideline by clinicians. The conclusions drawn from this Summit in Asia may serve as an important guide for other regions to follow.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Wang AY, Akizawa T, Bavanandan S, et al. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report. Kidney Int Rep. 2019. PMID: 31890994. doi:10.1016/j.ekir.2019.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。